RA
ANIP icon

Royce & Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Royce & Associates’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
+24,051
New +$1.88M 0.02% 589
2020
Q3 		– Sell
-1,036
Closed -$34K – 1000
2020
Q2 		$34K Buy
1,036
+333
+47% +$11.9K ﹤0.01% 1076
2020
Q1 		$29K Buy
703
+144
+26% +$7.66K ﹤0.01% 1070
2019
Q4 		$34K Buy
559
+44
+9% +$2.92K ﹤0.01% 1071
2019
Q3 		$38K Buy
515
+183
+55% +$13.7K ﹤0.01% 1080
2019
Q2 		$27K Sell
332
-62
-16% -$4.41K ﹤0.01% 1089
2019
Q1 		$28K Buy
394
+48
+14% +$2.82K ﹤0.01% 1102
2018
Q4 		$16K Sell
346
-58
-14% -$3.04K ﹤0.01% 1124
2018
Q3 		$23K Buy
+404
New +$24.7K ﹤0.01% 1140

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return